{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:38:07Z","timestamp":1771677487692,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":562,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1016\/j.lrr.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T15:42:17Z","timestamp":1353598937000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib"],"prefix":"10.1016","volume":"1","author":[{"given":"Tilde","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else","family":"Randers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Stentoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2012.09.002_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2009.07.009","article-title":"Renal failure associated with tyrosine kinase inhibitors\u2014case report and review of the literature","volume":"34","author":"Gafter-Gvil","year":"2010","journal-title":"Leukemia Research"},{"key":"10.1016\/j.lrr.2012.09.002_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.leukres.2008.07.029","article-title":"Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia","volume":"33","author":"Holstein","year":"2009","journal-title":"Leukemia Research"},{"key":"10.1016\/j.lrr.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ajh.22037","article-title":"Progressive peripheral occlusive disease and other vascular events during nilotinib therapy in CML","volume":"86","author":"Aichberger","year":"2011","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.lrr.2012.09.002_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ajh.22051","article-title":"Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia","volume":"86(7)","author":"Tefferi","year":"2011","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.lrr.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving Imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.lrr.2012.09.002_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/138920009788897975","article-title":"Tyrosine kinase inhibitors\u2014a review on pharmacology, metabolism and side effects","volume":"10","author":"Hartmann","year":"2009","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.lrr.2012.09.002_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mcna.2009.02.012","article-title":"Current approaches to renovascular hypertension","volume":"93","author":"Textor","year":"2009","journal-title":"Medical Clinics of North America"},{"key":"10.1016\/j.lrr.2012.09.002_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.leukres.2007.01.024","article-title":"Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib","volume":"31","author":"Breccia","year":"2007","journal-title":"Leukemia Research"},{"key":"10.1016\/j.lrr.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.109.207357","article-title":"Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis","volume":"105","author":"Franco","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/j.lrr.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1055\/s-0037-1613084","article-title":"New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells","volume":"87","author":"Valent","year":"2002","journal-title":"Thrombosis and Haemostasis"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048912000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048912000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:07Z","timestamp":1761959227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048912000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["S2213048912000040"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2012.09.002","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}